HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jiri Kassa Selected Research

Sarin

11/2020Influence of experimental end point on the therapeutic efficacy of the antinicotinic compounds MB408, MB442 and MB444 in treating nerve agent poisoned mice - a comparison with oxime-based treatment.
12/2019The evaluation of oxidative damage of DNA after poisoning with nerve agents.
1/2018Some benefit from non-oximes MB408, MB442 and MB444 in combination with the oximes HI-6 or obidoxime and atropine in antidoting sarin or cyclosarin poisoned mice.
1/2018The benefit of combinations of oximes for the ability of antidotal treatment to counteract sarin-induced brain damage in rats.
3/2015A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice.
11/2012A comparison of the potency of a novel bispyridinium oxime K203 and currently available oximes (obidoxime, HI-6) to counteract the acute neurotoxicity of sarin in rats.
5/2012The benefit of combination of oximes for the neuroprotective efficacy of antidotal treatment of sarin-poisoned rats.
7/2011The benefit of combinations of oximes for the reactivating and therapeutic efficacy of antidotal treatment of sarin poisoning in rats and mice.
9/2006The reactivating and therapeutic efficacy of oximes to counteract Russian VX poisonings.
7/2005Comparison of in vitro potency of oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited acetylcholinesterase in various parts of pig brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jiri Kassa Research Topics

Disease

57Poisoning
09/2022 - 07/2005
4Alzheimer Disease (Alzheimer's Disease)
01/2018 - 10/2008
1Amnesia (Dissociative Amnesia)
01/2018
1Disease Progression
12/2015
1Neurodegenerative Diseases (Neurodegenerative Disease)
06/2014
1Long Term Adverse Effects
05/2009
1Organophosphate Poisoning
10/2008
1Neurobehavioral Manifestations
10/2008
1Heart Failure
09/2008

Drug/Important Bio-Agent (IBA)

48OximesIBA
09/2022 - 07/2005
28tabunIBA
09/2022 - 12/2006
20asoxime chloride (H16)IBA
01/2018 - 07/2005
15AtropineFDA LinkGeneric
10/2020 - 01/2007
14Nerve AgentsIBA
04/2022 - 12/2006
13SomanIBA
10/2021 - 09/2006
11Obidoxime Chloride (Obidoxime)IBA
01/2018 - 01/2007
10SarinIBA
11/2020 - 07/2005
10Trimedoxime (Trimedoxime Bromide)IBA
07/2017 - 09/2007
9cyclohexyl methylphosphonofluoridate (cyclosarin)IBA
11/2020 - 09/2006
7AcetylcholinesteraseIBA
03/2015 - 01/2007
4Cholinesterase Inhibitors (Anticholinesterases)IBA
10/2021 - 12/2015
3Tacrine (Cognex)FDA Link
01/2016 - 10/2008
3VX (EDIM)IBA
08/2013 - 09/2006
2Biological ProductsIBA
04/2022 - 11/2015
2MB442IBA
04/2018 - 01/2018
2MB444IBA
04/2018 - 01/2018
2MB408IBA
04/2018 - 01/2018
21- (4- carbamoylpyridinium)- 4- (3- fluoro- 4- hydroxyiminomethylpyridinium)- but- 2- eneIBA
11/2010 - 08/2010
2p38 Mitogen-Activated Protein KinasesIBA
05/2009 - 01/2007
2Transcription Factors (Transcription Factor)IBA
05/2009 - 01/2007
2Neuroprotective AgentsIBA
01/2009 - 01/2007
2Cholinergic Antagonists (Anticholinergics)IBA
10/2008 - 12/2006
2Pharmaceutical PreparationsIBA
10/2008 - 12/2006
1Memantine (Namenda)FDA Link
10/2021
1Paraoxon (E600)IBA
10/2020
1OrganophosphatesIBA
10/2020
1DNA (Deoxyribonucleic Acid)IBA
12/2019
1Quinuclidinyl BenzilateIBA
01/2018
16-chlorotacrineIBA
01/2018
1MB327IBA
06/2016
1PropaneIBA
06/2016
1Cholinesterases (Cholinesterase)IBA
01/2016
16- hydroxy- 2,5,7,8- tetramethylchroman- 2- carboxylic acid (Trolox)IBA
11/2015
1Cholinergic ReceptorsIBA
06/2014
11- (4- carbamoylpyridinium)- 3- (4- hydroxyiminomethylpyridinium)- 2- oxapropaneIBA
03/2011
17- methoxy- 1,2,3,4- tetrahydroacridin- 9- amineIBA
10/2008
17-methoxytacrine (TA 03)IBA
10/2008
1Cholinesterase ReactivatorsIBA
10/2008
1Malathion (Karbofos)FDA LinkGeneric
01/2008
1Glutathione PeroxidaseIBA
01/2008
1Cholinergic Agents (Cholinergics)IBA
01/2008
1Glutathione (Reduced Glutathione)IBA
01/2008
1Glutathione Reductase (Glutathione-Disulfide Reductase)IBA
01/2008
1AntidotesIBA
09/2007
1Mitogen-Activated Protein KinasesIBA
01/2007
1Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric
12/2006
1BenactyzineIBA
12/2006
1panpalIBA
12/2006
1S-(N,N-diethylaminoethyl) isobutyl methylphosphothiolateIBA
09/2006

Therapy/Procedure

2Therapeutics
10/2020 - 01/2016